NYSEARCA:PBEInvesco Dynamic Biotechnology & Genome ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Invesco Dynamic Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $60.39 +0.45 (+0.75 %) (As of 07/13/2020 10:47 AM ET) Add Share Today's Range$60.34Now: $60.39▼$60.5350-Day Range$53.13MA: $57.40▼$60.8352-Week Range$38.08Now: $60.39▼$61.23Volume585 shsAverage Volume11,706 shsMarket Capitalization$247.60 millionP/E RatioN/ADividend Yield0.05%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesSocial Media PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.Read More Geographic Exposure of PBECurrency Exposure of PBESector Exposure of PBEIndustry Exposure of PBE Basic Details Issuer Invesco Fund NameInvesco Dynamic Biotechnology & Genome ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:PBE Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon Webwww.invescopowershares.com Phone+1-800-9830903 Fund Focus Asset ClassEquity BenchmarkDynamic Biotechnology & Genome Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$245.69 million Average Daily Volume$7,763.10 Discount/Premium0.02% ETF Expenses Management Fee0.50% Other Expenses0.08% Total Expenses0.58% Fee Waiver0.00% Net Expenses0.58%Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation Trustee Lead Market MakerCitadel AMEX:PBE Rates by TradingView Receive PBE News and Ratings via Email Sign-up to receive the latest news and ratings for PBE and its competitors with MarketBeat's FREE daily newsletter. Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Frequently Asked Questions How has Invesco Dynamic Biotechnology & Genome ETF's stock been impacted by COVID-19 (Coronavirus)? Invesco Dynamic Biotechnology & Genome ETF's stock was trading at $45.90 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, PBE shares have increased by 31.6% and is now trading at $60.39. View which stocks have been most impacted by Coronavirus. Has Invesco Dynamic Biotechnology & Genome ETF been receiving favorable news coverage? Press coverage about PBE stock has trended very negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Invesco Dynamic Biotechnology & Genome ETF earned a news impact score of -3.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about Invesco Dynamic Biotechnology & Genome ETF. What other stocks do shareholders of Invesco Dynamic Biotechnology & Genome ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Biotechnology & Genome ETF investors own include Align Technology (ALGN), Activision Blizzard (ATVI), Netflix (NFLX), Boeing (BA), Mastercard (MA), Micron Technology (MU), NVIDIA (NVDA), Paypal (PYPL), Visa (V) and Wayfair (W). Who are Invesco Dynamic Biotechnology & Genome ETF's key executives? Invesco Dynamic Biotechnology & Genome ETF's management team includes the following people: H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive OfficerBruce T. Duncan, Chief Financial Officer, TreasurerKevin R. Gustafson, Chief Compliance OfficerKeith A Ovitt, SecretaryRonn R. Bagge, TrusteeMarc M Kole, TrusteeD. Mark McMillan, TrusteePhilip M. Nussbaum Mba, TrusteeDonald H. Wilson, Trustee What is Invesco Dynamic Biotechnology & Genome ETF's stock symbol? Invesco Dynamic Biotechnology & Genome ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PBE." Who are Invesco Dynamic Biotechnology & Genome ETF's major shareholders? Invesco Dynamic Biotechnology & Genome ETF's stock is owned by many different retail and institutional investors. Top institutional investors include Joseph P. Lucia & Associates LLC (0.02%). Which major investors are selling Invesco Dynamic Biotechnology & Genome ETF stock? PBE stock was sold by a variety of institutional investors in the last quarter, including Joseph P. Lucia & Associates LLC. How do I buy shares of Invesco Dynamic Biotechnology & Genome ETF? Shares of PBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Invesco Dynamic Biotechnology & Genome ETF's stock price today? One share of PBE stock can currently be purchased for approximately $60.39. How big of a company is Invesco Dynamic Biotechnology & Genome ETF? Invesco Dynamic Biotechnology & Genome ETF has a market capitalization of $247.60 million. What is Invesco Dynamic Biotechnology & Genome ETF's official website? The official website for Invesco Dynamic Biotechnology & Genome ETF is www.invescopowershares.com. How can I contact Invesco Dynamic Biotechnology & Genome ETF? Invesco Dynamic Biotechnology & Genome ETF's mailing address is 301 West Roosevelt Road, WHEATON, IL 60187, United States. The company can be reached via phone at +1-800-9830903. This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
